Cardio Diagnostics Holdings, Inc. Increase Decrease In Operating Lease Liability
Cardio Diagnostics Holdings, Inc. (CDIO) reported Increase Decrease In Operating Lease Liability of -$123.58 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-07
- Cardio Diagnostics Holdings, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$62.13K.
- Cardio Diagnostics Holdings, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$61.45K.
- Cardio Diagnostics Holdings, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$60.77K.
- Cardio Diagnostics Holdings, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$59.84K.
- Cardio Diagnostics Holdings, Inc. increase decrease in operating lease liability for fiscal 2025 was -$237.27K.
- Cardio Diagnostics Holdings, Inc. increase decrease in operating lease liability for fiscal 2024 was -$223.93K, a 191.58% decline from fiscal 2023.
- Cardio Diagnostics Holdings, Inc. increase decrease in operating lease liability for fiscal 2023 was $244.50K.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$62.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$123.58K 10-Q · filed 2026-08-07 | -$184.35K derived: sum of 3 quarters · filed 2026-08-07 | -$244.18K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$61.45K 10-Q · filed 2026-05-15 | -$122.21K derived: sum of 2 quarters · filed 2026-05-15 | -$182.05K derived: sum of 3 quarters · filed 2026-05-15 | -$240.71K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$60.77K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$120.60K derived: sum of 2 quarters · filed 2026-03-13 | -$179.26K derived: sum of 3 quarters · filed 2026-08-07 | -$237.27K 10-K · filed 2026-03-13 |
| 2025-09-30 | -$59.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$118.49K derived: sum of 2 quarters · filed 2026-08-07 | -$176.50K 10-Q · filed 2025-11-12 | -$233.87K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$58.66K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$116.67K 10-Q · filed 2026-08-07 | -$174.03K derived: sum of 3 quarters · filed 2026-08-07 | -$230.51K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$58.01K 10-Q · filed 2026-05-15 | -$115.38K derived: sum of 2 quarters · filed 2026-05-15 | -$171.86K derived: sum of 3 quarters · filed 2026-05-15 | -$227.20K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$57.37K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | -$113.85K derived: sum of 2 quarters · filed 2026-03-13 | -$169.19K derived: sum of 3 quarters · filed 2026-03-13 | -$223.93K 10-K · filed 2026-03-13 |
| 2024-09-30 | -$56.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$111.83K derived: sum of 2 quarters · filed 2025-11-12 | -$166.56K 10-Q · filed 2025-11-12 | $71.39K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$55.34K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$110.08K 10-Q · filed 2025-08-14 | $127.87K derived: sum of 3 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$54.73K 10-Q · filed 2025-05-15 | $183.21K derived: sum of 2 quarters · filed 2025-05-15 | ||
| 2023-12-31 | $237.95K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $244.50K 10-K · filed 2025-03-20 | ||
| 2023-09-30 | $6.56K 10-Q · filed 2024-11-13 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |